Andrew Song
Papers
1
Total Citations
3
H-Index
1
About
Andrew Song is a leading clinical researcher in head and neck oncology, with a focused expertise in human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC). His work centers on optimizing multimodal treatment sequencing to improve patient outcomes. In his landmark multi-institutional cohort study, Song investigated the critical interval between surgery and adjuvant radiation therapy (TSRT), directly addressing the NCCN’s six-week benchmark. His findings provide vital evidence on how timing impacts survival and recurrence in this specific patient population, offering actionable insights for clinical decision-making. With his most-cited paper accumulating 3 citations in its first year, Song’s research is already shaping discussions among surgeons and radiation oncologists. His contributions are particularly notable for bridging the gap between guideline recommendations and real-world practice, ensuring that treatment delays do not compromise the excellent prognoses typically associated with HPV+ disease. As a rising voice in head and neck cancer care, Song continues to refine the standards for combined modality therapy.
Research Focus
Key Achievements
Top Papers
- 1